Profile
CRVO VRTX VRNA REGN ALNY ARGX
Company Name CervoMed Inc. Vertex Pharmaceuticals Incorporated Verona Pharma plc Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $65.23M $108.04B $72.68B $67.32B $58.93B $50.06B
Employees 0.02K 6.10K 0.21K 15.16K 2.23K 1.60K
CEO John J. Alam Reshma Kewalramani FASN, David S. Zaccardelli Leonard S. Schleifer Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
CRVO VRTX VRNA REGN ALNY ARGX
Quant Rating Score 2 3 1 4 2 4
Quant Rating Sell Neutral Strong Sell Buy Sell Buy
Trading
CRVO VRTX VRNA REGN ALNY ARGX
Last Close $7.05 $425.57 $106.91 $651.8 $456.04 $818.5
High 52 $14.29 $516.74 $106.91 $843.6 $491.09 $849.46
Low 52 $1.9 $366.54 $34.98 $482.92 $224.58 $532.27
Price vs. 52 Week High -50.66 % -17.64 % 0 % -22.74 % -7.14 % -3.64 %
Price vs. 52 Week Low 271.05 % 16.1 % 205.63 % 34.97 % 103.06 % 53.78 %
Total Return
CRVO VRTX VRNA REGN ALNY ARGX
1 Month Return -13.71 % 4.09 % 0.08 % 8.66 % -1.12 % 3.4 %
3 Month Return -20.16 % -7.91 % 1.64 % 16.63 % 13.5 % 21.48 %
6 Month Return -31.22 % -15.08 % 47 % 7.63 % 75.81 % 25.99 %
9 Month Return 211.95 % -7.82 % 86.58 % -3.15 % 68.09 % 24.94 %
YTD Return 201.28 % 5.68 % 130.21 % -8.5 % 93.8 % 33.09 %
1 Year Return -44.96 % -9.67 % 205.63 % -22.74 % 66.49 % 37.43 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CRVO VRTX VRNA REGN ALNY ARGX
Dividend Yield Percentage (TTM) - - - 0.41 % - -
Dividend Paid and Capex Coverage Ration (TTM) -5310674.4 % 11.09 % -147.93 % 4.25 % 5.97 % 65.28 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 6.06 % - -
Growth
CRVO VRTX VRNA REGN ALNY ARGX
Asset Growth 332 % 53.91 %
Gross Profit Growth -600.15 % 5941.02 %
Revenue Growth 36.29 % -
Revenue 3 Year - -23.33 %
Revenue 5 Year - 290254.46 %
Revenue 10 Year - -
EBIT Growth -739.18 % -162.64 %
Net Income Growth -650.05 % -218.96 %
Net Income 3 Yeari Growth Per Share 89.1 % -126.38 %
Net Income 5 Yeari Growth Per Share 98.47 % 33.14 %
Net Income 10 Yeari Growth Per Share 99.98 % -7.28 %
Operating Income Growth -133.29 % -127.96 %
Operating Cash Flow Growth (CFG) -121.89 % -143.33 %
Operating 3 Year CFG 81.62 % -166.57 %
Operating 5 Year CFG 98.14 % 55.51 %
Operating 10 Year CFG 99.97 % 41.1 %
EPS Growth -146.34 % -200 %
EPS Diluted Growth -146.34 % -215.05 %
Book Value Per Share 75.17 % -24.01 %
Share Holder 3 Year Equity Growth Per Share -81.89 % 0.26 %
Share Holder 5 Year Equity Growth Per Share -97.84 % -25.62 %
Share Holder 10 Year Equity Growth Per Share -99.98 % -72.3 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth - 139.05 %
Free Cash Flow Growth -121.89 % -144.48 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
CRVO VRTX VRNA REGN ALNY ARGX
Gross Profit Margin TTM -141.84 % 86.11 % 95.15 % 85.39 % 51.22 % 65.82 %
Return on Assets TTM -59.38 % 15.13 % -14.17 % 11.4 % 0.9 % 15.06 %
Return on Equity TTM -59.15 % 22.14 % -38.66 % 15.31 % 26.13 % 18.96 %
Return on Capital Employed TTM -67.77 % 19.72 % -10.74 % 10.32 % 8.03 % 5.04 %
Net Income Per EBT TTM 100 % 83.16 % 111.3 % 88.98 % -136.38 % 237.3 %
EBT Per Ebit TTM 92.08 % 111.48 % 130.22 % 139.5 % -12.07 % 147.38 %
EBIT Per Revenue TTM -315.77 % 34.36 % -25.27 % 25.89 % 8.25 % 13.47 %
Cash Flow To Debt Ratio TTM - 251.83 % -29.66 % 187.43 % 20.32 % 932.29 %
Receivables Turnover TTM 3.29 6.03 2.55 2.51 3.33 1.91
Payables Turnover TTM 9.24 3.59 3.13 2.3 2.69 0.9
Inventory Turnover TTM - 1.06 1.25 0.64 4.2 2.26
Fixed Asset Turnover TTM - 431.08 % 8642.22 % 284.82 % 463.12 % 5009.77 %
Asset Turnover TTM 20.42 % 47.51 % 38.7 % 35.47 % 66.16 % 31.97 %
Operating Cash Flow Per Share TTM -2.97 14.98 -0.85 48.94 2.02 5.67
Free Cash Flow Per Share TTM -2.97 13.63 -0.85 40.09 1.68 5.58
Cash Per Share TTM 374.63 % 2486.48 % 511.44 % 8148.65 % 2072.79 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -341.45 % 33.68 % -32.7 % 35.59 % 8.28 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 90.99 % 100.75 % 81.92 % 83.26 % 98.47 %
Cash Flow Coverage Ratios TTM - 251.83 % -29.66 % 187.43 % 20.32 % 932.29 %
Price To Free Cash Flows Ratio TTM -2.46 30.87 -995.27 16.2 266.2 126.32
Price To Operating Cash Flows Ratio TTM -2.38 28.12 -126.33 13.32 222.27 144.28
Price Cash Flow Ratio TTM -2.38 28.12 -126.33 13.32 222.27 144.28
Income Statement (TTM)
CRVO VRTX VRNA REGN ALNY ARGX
Revenue $0.01B $11.02B $0.03B $14.2B $2.25B $2.19B
Gross Profit $-0.01B $9.49B $0.03B $12.23B $1.92B $1.96B
Gross Profit Ratio -93.04% 86.11% 93.89% 86.13% 85.62% 89.62%
EBITDA $-0.02B $0.49B $-0.12B $5.32B $-0.18B $0.11B
Net Income $-0.02B $-0.54B $-0.14B $4.41B $-0.28B $0.83B
EPS Diluted -2.02 -2.08 -1.73 38.34 -2.18 12.78
Balance Sheet (MRQ)
CRVO VRTX VRNA REGN ALNY ARGX
Long Term Debt $0B $1.66B $0.12B $2.7B $1.25B $0.03B
Total Liabilities $0B $6.12B $0.27B $8.41B $4.17B $0.7B
Total Equity $0.04B $16.41B $0.2B $29.35B $0.07B $5.5B
Total Investments $0.03B $6.65B $0.02B $15.42B $1.73B $1.93B
Total Debt $0B $1.75B $0.12B $2.7B $1.3B $0.04B
Total Assets $0.04B $22.53B $0.47B $37.76B $4.24B $6.2B
Cash Flow Statement (TTM)
CRVO VRTX VRNA REGN ALNY ARGX
Net Income $-0.02B $-0.54B $-0.17B $4.41B $-0.28B $0.83B
Inventory $0B $-0.52B $-0.01B $-0.62B $0.01B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $-0.12B $4.42B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0B $-0.76B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 33.42
AARD Aardvark Therapeutics, Inc. Common Stock 10.69
ABCL AbCellera Biologics Inc. 5.55
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.81
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.21
ABPWW 0.0142
ABSI Absci Corporation 4.28
ABUS Arbutus Biopharma Corporation 4.73
ABVC ABVC BioPharma, Inc. 2.8
ABVX Abivax SA American Depositary Shares 102.42
ACAD ACADIA Pharmaceuticals Inc. 22.7
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.75
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 5.12
ACIU AC Immune SA 3.38
ETFs With Exposure to CRVO
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00008 246.23
VTI Vanguard Total Stock Market Index Fund 0.0001 335.42
IWO iShares Russell 2000 Growth ETF 0.00014 330.69
VXF Vanguard Extended Market Index Fund 0.00052 211.74
HDG ProShares Hedge Replication ETF 0.000195933 51.6656
UWM ProShares Ultra Russell2000 0.00115528 47.65
VTHR Vanguard Russell 3000 Index Fund 0 300.857
IWC iShares Micro-Cap ETF 0.0091 156.22
URTY ProShares UltraPro Russell2000 0.00092375 54.67
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0 74.67
VTWG Vanguard Russell 2000 Growth Index Fund 0.00302 241.414
VTWO Vanguard Russell 2000 Index Fund 0.00157 99.54
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 46.97
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00005 114.06
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 114.04
BMED BlackRock Future Health ETF 0.01001 28.525
VTSAX Vanguard Total Stock Market Index Fund 0.0001 163.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00052 160.7
VITSX Vanguard Total Stock Market Index Fund 0.0001 163.27
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00052 160.71
AVSC Avantis U.S. Small Cap Equity ETF 0 57.31
VTS.AX Vanguard US Total Market Shares Index ETF 0.00012 513.69
VEMPX Vanguard Extended Market Index InstlPlus 0.00052 396.57
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.0001 306.27
RSSL Global X Funds 0 96.68
Unlock